Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT)
CUSIP: 59503A204
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common stock, par value $0.01 per share
- Shares outstanding
- 73,197,378
- Total 13F shares
- 701,275
- Share change
- +117,522
- Total reported value
- $3,888,006
- Price per share
- $5.51
- Number of holders
- 19
- Value change
- +$236,511
- Number of buys
- 13
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 59503A204?
CUSIP 59503A204 identifies MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 59503A204:
Top shareholders of MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.26%
|
188,775
|
$1,920,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.25%
|
182,896
|
$1,860,000 | — | 31 Dec 2019 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
76,000
|
$773,000 | — | 31 Dec 2019 | |
| Virtu Financial LLC |
13F
|
Company |
0.08%
|
59,598
|
$606,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.06%
|
46,177
|
$470,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
41,965
|
$426,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
26,321
|
$268,000 | — | 31 Dec 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
13,300
|
$135,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
4,087
|
$42,000 | — | 31 Dec 2019 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
3,000
|
$30,000 | — | 31 Dec 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
600
|
$6,000 | — | 31 Dec 2019 | |
| Kore Private Wealth LLC |
13F
|
Company |
0%
|
225
|
$2,000 | — | 31 Dec 2019 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
201
|
$2,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
201
|
$2,000 | — | 31 Dec 2019 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
4
|
$41 | — | 31 Dec 2019 | |
| RBC Europe Ltd |
13F
|
Company |
0%
|
1
|
$10 | — | 31 Dec 2019 |
Institutional Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q1 2020
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.